Lirentelimab Reduces Levels of Inflammatory Cytokines in Tear Fluid From Patients With Allergic Conjunctivitis

lirentelimab (AK002) - Allakos

P. Asbell1; N. Roy2; A. Fernandez1; A. Kantor3; A. Chang3; B. Singh3; B. Youngblood3

Apr 30, 2022